Cloning, expression and purification of feline proinsulin

Domestic Animal Endocrinology

Volumn 30, Issue 1, 2006, Pages 28-37

  Hoenig, M ^a   Caffall, Z F ^a   McGraw, R A ^a   Ferguson, D C ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Assay; Beta cell; Cats; Diabetes; Insulin

Indexed keywords

PROINSULIN; RECOMBINANT PROTEIN; RNA;

AMINO ACID SEQUENCE; ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CHEMISTRY; DNA SEQUENCE; GENETICS; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PLASMID; PROTEIN FOLDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CATS; CLONING, MOLECULAR; MOLECULAR SEQUENCE DATA; PLASMIDS; PROINSULIN; PROTEIN FOLDING; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA;

BACTERIA (MICROORGANISMS); FELIDAE;

EID: 27844541205     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2005.05.005     Document Type: Article

References (20)

1. M. Hoenig, C. Reusch, and M.E. Peterson Beta cell and insulin antibodies in treated and untreated diabetic cats Vet Immunol Immunopathol 77 2000 93 102
2. K.H. Johnson, T.D. O'Brien, and P. Westermark Islet amyloid, islet amyloid polypeptide, and diabetes mellitus New Engl J Med 321 1989 513 518
3. P.A. Halban Proinsulin processing in the regulated and the constitutive secretory pathway Diabetologia 37 Suppl. 2 1994 S65 S72
4. A. Pfützner, T. Kunt, C. Hohberg, A. Mondok, S. Pahler, and T. Konrad Fasting intact proinsulin is a highly specific indicator of insulin resistance in type 2 diabetes Diabetes Care 27 2004 682 687
5. A. Festa, R. D'Agostino, L. Mykkänen, R.P. Tracy, C.N. Hales, and B.V. Howard LDL particle size in relation to insulin, proinsulin, and insulin sensitivity Diabetes Care 22 1999 1688 1693
6. Heanut A, Danchin A. In: Neidhardt F, Curtiss III R, Ingraham J, Lin E, Low B, Magasanik B, Reznikoff W, Riley M, Schaechter M, Umbarger H, editor. Escherichia coli and Salmonella typhimurium cellular and molecular biology, vol. 2. Washington, DC: American Society for Microbiology; 1996. pp. 2047-66.
7. M. Bradford A rapid and sensitive method for the quantitation on microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
8. R.B. Mackin, and M.H. Choquette Expression, purification and PC1-mediated processing of (H10D, P28K, K29P)-human proinsulin Protein Expr Purif 27 2003 210 219
9. G. Hallden, G. Gafvelin, V. Mutt, and H. Jornvall Characterization of cat insulin Arch Biochem Biophys 247 1986 20 27
10. T.A. Buchanan Pancreatic beta-cell loss and preservation in type 2 diabetes Clin Ther 25 2003 B32 B46
11. L. Palaniappan, M.R. Carnethon, Y. Wang, A.J. Hanley, S.P. Fortmann, and S.M. Haffner Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study Diabetes Care 27 2004 788 793
12. C. Alarcón, J.L. Leahy, G.T. Schuppin, and C.J. Rhodes Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus J Clin Invest 95 3 1995 1032 1039
13. S.M. Haffner, C. Gonzalez, L. Mykkänen, and M. Stern Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study Diabetologia 40 7 1997 830 837
14. S.M. Haffner, M.P. Stern, H. Miettinen, R. Gingerich, and R.R. Bowsher Higher proinsulin and specific insulin are both associated with a parental history of diabetes in nondiabetic Mexican-American subjects Diabetes 44 1995 1156 1160
15. L.S. Hermann, J. Ranstam, S. Vaaler, and A. Melander Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type 2 diabetes Diabetes Obes Metab 1 1999 227 232
16. M. Hoenig, G. Hall, D. Ferguson, J. Jordan, M. Henson, and K. Johnson A feline model of experimentally induced islet amyloidosis Am J Pathol 157 2000 2143 2150
17. M.W. Steffes, S. Sibley, M. Jackson, and W. Thomas Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial Diabetes Care 26 2003 832 836
18. M.R. Lebowitz, and S.A. Blumenthal The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration Arch Intern Med 153 1993 650 655
19. N.K. Chammas, J.D. Teale, and J.D. Quin Insulinoma: how reliable is the biochemical evidence? Ann Clin Biochem 40 2003 689 693
20. J. Wahren C-peptide: new findings and therapeutic implications in diabetes Clin Physiol Funct Imaging 24 2004 180 189